Moderna, Inc. (MRNA)
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
The Food and Drug Administration approved Moderna's vaccine for respiratory syncytial virus. The decision is a win for Moderna, which desperately needs another revenue source amid plunging demand for its Covid jab, its only commercially available product.
US FDA approves Moderna's RSV vaccine, its second marketed product
The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.
Why Moderna Stock Is Sinking This Week
Investors appear to be taking profits after Moderna stock soared last week. The big moves center around concerns about the H5N1 avian flu, also known as bird flu.
Moderna Pops After Confirming The U.S. Government Could Back Its Bird Flu Vaccine
Moderna stock jumped early Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.
Moderna's stock climbs on report that bird-flu vaccine funding is near
Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.
Option Trade On Volatile Moderna Could Return 28% By Mid-July
This iron condor trade on Moderna has the potential to return 28% if the stock price stays between 118.90 and 181.10.
U.S. Government Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
The U.S. government is closing in on a deal to fund a late-stage trial for an mRNA pandemic bird flu vaccine made by Moderna, the Financial Times reported Thursday, at a time when the country is battling an H5N1 outbreak in cattle and poultry farms.
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA pandemic bird flu vaccine, the Financial Times reported on Thursday, as an H5N1 outbreak spreads through egg farms and among cattle herds.
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Biotech stocks are not for the faint of heart. It is a sector that can provide life-changing gains or cause an investment to head towards zero.
Moderna Shares Had a Bad Day. Here's Why.
The drop comes as Moderna awaits important developments involving its experimental cancer treatment, a new respiratory vaccine, and a possible avian flu vaccine under development.
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Shares of Moderna (MRNA) are being driven by encouraging pipeline updates and plans for potential product launches.
